Dr. van 't Veer on Guidelines for Genetic Testing in Breast Cancer

Laura van 't Veer, PhD
Published: Friday, Oct 27, 2017



Laura van ’t Veer, PhD, Leader of the Breast Oncology Program, and director of Applied Genomics, UCSF Helen Diller Family Comprehensive Cancer Center, discusses the guidelines for genetic testing in breast cancer.

For women who are diagnosed with breast cancer and have a family history, the guidelines for genetic testing are quite clear. But information of genetic risk is relevant for every woman, regardless of family history, states van ‘t Veer.

Nowadays, physicians can look at the genetics of a given patient for a risk score to advise screening decisions.
 


Laura van ’t Veer, PhD, Leader of the Breast Oncology Program, and director of Applied Genomics, UCSF Helen Diller Family Comprehensive Cancer Center, discusses the guidelines for genetic testing in breast cancer.

For women who are diagnosed with breast cancer and have a family history, the guidelines for genetic testing are quite clear. But information of genetic risk is relevant for every woman, regardless of family history, states van ‘t Veer.

Nowadays, physicians can look at the genetics of a given patient for a risk score to advise screening decisions.
 



View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Clinical Interchange™: Translating Research to Inform Changing Paradigms: Assessment of Emerging Immuno-Oncology Strategies and Combinations across Lung, Head and Neck, and Bladder CancersOct 31, 20182.0
Community Practice Connections: Oncology Best Practice™ Targeting Cell Cycle Progression: The Latest Advances on CDK4/6 Inhibition in Metastatic Breast CancerOct 31, 20181.0
Publication Bottom Border
Border Publication
x